These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38361239)

  • 21. Long-Term Bacterial and Fungal Dynamics following Oral Lyophilized Fecal Microbiota Transplantation in Clostridioides difficile Infection.
    Haifer C; Paramsothy S; Borody TJ; Clancy A; Leong RW; Kaakoush NO
    mSystems; 2021 Feb; 6(1):. PubMed ID: 33531405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of the Gut Microbiome to Drug Disposition, Pharmacokinetic and Pharmacodynamic Variability.
    Tsunoda SM; Gonzales C; Jarmusch AK; Momper JD; Ma JD
    Clin Pharmacokinet; 2021 Aug; 60(8):971-984. PubMed ID: 33959897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbiota restoration reduces antibiotic-resistant bacteria gut colonization in patients with recurrent Clostridioides difficile infection from the open-label PUNCH CD study.
    Langdon A; Schwartz DJ; Bulow C; Sun X; Hink T; Reske KA; Jones C; Burnham CD; Dubberke ER; Dantas G;
    Genome Med; 2021 Feb; 13(1):28. PubMed ID: 33593430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gram-Negative Taxa and Antimicrobial Susceptibility after Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
    Steed DB; Wang T; Raheja D; Waldman AD; Babiker A; Dhere T; Kraft CS; Woodworth MH
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33055258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The alteration of the gut microbiome by immunosuppressive agents used in solid organ transplantation.
    Gibson CM; Childs-Kean LM; Naziruddin Z; Howell CK
    Transpl Infect Dis; 2021 Feb; 23(1):e13397. PubMed ID: 32609940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacomicrobiomics in Anticancer Therapies: Why the Gut Microbiota Should Be Pointed Out.
    Conti G; D'Amico F; Fabbrini M; Brigidi P; Barone M; Turroni S
    Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations and Prediction of Functional Profiles of Gut Microbiota After Fecal Microbiota Transplantation for Iranian Recurrent
    Azimirad M; Jo Y; Kim MS; Jeong M; Shahrokh S; Asadzadeh Aghdaei H; Zali MR; Lee S; Yadegar A; Shin JH
    J Inflamm Res; 2022; 15():105-116. PubMed ID: 35023946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
    Khanna S; Assi M; Lee C; Yoho D; Louie T; Knapple W; Aguilar H; Garcia-Diaz J; Wang GP; Berry SM; Marion J; Su X; Braun T; Bancke L; Feuerstadt P
    Drugs; 2022 Oct; 82(15):1527-1538. PubMed ID: 36287379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrent Clostridioides difficile Infection: Current Clinical Management and Microbiome-Based Therapies.
    Berry P; Khanna S
    BioDrugs; 2023 Nov; 37(6):757-773. PubMed ID: 37493938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New insights into the microbiome in kidney transplantation.
    Kim JS; Sze C; Barbar T; Lee JR
    Curr Opin Organ Transplant; 2021 Dec; 26(6):582-586. PubMed ID: 34534173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional profile of host microbiome indicates
    Nzabarushimana E; Tang H
    Gut Microbes; 2022; 14(1):2135963. PubMed ID: 36289064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clearance of Clostridioides difficile Colonization Is Associated with Antibiotic-Specific Bacterial Changes.
    Lesniak NA; Schubert AM; Sinani H; Schloss PD
    mSphere; 2021 May; 6(3):. PubMed ID: 33952668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in Composition of the Gut Bacterial Microbiome after Fecal Microbiota Transplantation for Recurrent
    Flannigan KL; Rajbar T; Moffat A; McKenzie LS; Dicke F; Rioux K; Workentine ML; Louie TJ; Hirota SA; Greenway SC
    Front Cardiovasc Med; 2017; 4():17. PubMed ID: 28421185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbiome Resilience despite a Profound Loss of Minority Microbiota following Clindamycin Challenge in Humanized Gnotobiotic Mice.
    Liu L; Kirst ME; Zhao L; Li E; Wang GP
    Microbiol Spectr; 2022 Feb; 10(1):e0196021. PubMed ID: 35019780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Butyrate Differentiates Permissiveness to Clostridioides difficile Infection and Influences Growth of Diverse C. difficile Isolates.
    Pensinger DA; Fisher AT; Dobrila HA; Van Treuren W; Gardner JO; Higginbottom SK; Carter MM; Schumann B; Bertozzi CR; Anikst V; Martin C; Robilotti EV; Chow JM; Buck RH; Tompkins LS; Sonnenburg JL; Hryckowian AJ
    Infect Immun; 2023 Feb; 91(2):e0057022. PubMed ID: 36692308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Key determinants of success in fecal microbiota transplantation: From microbiome to clinic.
    Porcari S; Benech N; Valles-Colomer M; Segata N; Gasbarrini A; Cammarota G; Sokol H; Ianiro G
    Cell Host Microbe; 2023 May; 31(5):712-733. PubMed ID: 37167953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synbiotics, prebiotics and probiotics for solid organ transplant recipients.
    Cooper TE; Scholes-Robertson N; Craig JC; Hawley CM; Howell M; Johnson DW; Teixeira-Pinto A; Jaure A; Wong G
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD014804. PubMed ID: 36126902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacomicrobiomics: The Holy Grail to Variability in Drug Response?
    Sharma A; Buschmann MM; Gilbert JA
    Clin Pharmacol Ther; 2019 Aug; 106(2):317-328. PubMed ID: 30937887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut Pharmacomicrobiomics: the tip of an iceberg of complex interactions between drugs and gut-associated microbes.
    Saad R; Rizkallah MR; Aziz RK
    Gut Pathog; 2012 Nov; 4(1):16. PubMed ID: 23194438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Gut Bacterial Community Potentiates Clostridioides difficile Infection Severity.
    Lesniak NA; Schubert AM; Flynn KJ; Leslie JL; Sinani H; Bergin IL; Young VB; Schloss PD
    mBio; 2022 Aug; 13(4):e0118322. PubMed ID: 35856563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.